0000313616-20-000123.txt : 20200723 0000313616-20-000123.hdr.sgml : 20200723 20200723062428 ACCESSION NUMBER: 0000313616-20-000123 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20200723 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200723 DATE AS OF CHANGE: 20200723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 201042684 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 8-K 1 dhr-2020723x8k.htm 8-K Document
false0000313616 0000313616 dhr:A2.5SeniorNotesDue2025Member 2020-07-23 2020-07-23 0000313616 dhr:A0.45SeniorNotesDue2028Member 2020-07-23 2020-07-23 0000313616 dhr:A1.7SeniorNotesDue2024Member 2020-07-23 2020-07-23 0000313616 dhr:A1.35SeniorNotesDue2039Member 2020-07-23 2020-07-23 0000313616 us-gaap:SeriesBPreferredStockMember 2020-07-23 2020-07-23 0000313616 dhr:A1.7SeniorNotesDue2022Member 2020-07-23 2020-07-23 0000313616 dhr:A1.8SeniorNotesDue2049Member 2020-07-23 2020-07-23 0000313616 dhr:A0.75SeniorNotesDue2031Member 2020-07-23 2020-07-23 0000313616 us-gaap:SeriesAPreferredStockMember 2020-07-23 2020-07-23 0000313616 us-gaap:CommonStockMember 2020-07-23 2020-07-23 0000313616 dhr:A2.1SeniorNotesDue2026Member 2020-07-23 2020-07-23 0000313616 dhr:A1.2SeniorNotesDue2027Member 2020-07-23 2020-07-23 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2020-07-23 2020-07-23 0000313616 dhr:A2.5SeniorNotesDue2030Member 2020-07-23 2020-07-23 0000313616 dhr:A0.2SeniorNotesDue2026Member 2020-07-23 2020-07-23 0000313616 2020-07-23 2020-07-23


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 23, 2020
__________________
dhrlogofor8ksa63.jpg
DANAHER CORPORATION
 
(Exact Name of Registrant as Specified in Its Charter)
 
__________________
Delaware
001-08089
59-1995548
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
 
 
2200 Pennsylvania Avenue, N.W.,
 
20037-1701
Suite 800W,
 
Washington,
DC
 
(Address of Principal Executive Offices)
 
(Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
DHR
New York Stock Exchange
4.75% Mandatory Convertible Preferred Stock, Series A, without par value
DHR.PRA
New York Stock Exchange
5.00% Mandatory Convertible Preferred Stock, Series B, without par value
DHR.PRB
New York Stock Exchange
Floating Rate Senior Notes due 2022
DHR F 06/30/22
New York Stock Exchange
1.700% Senior Notes due 2022
DHR 1.7 01/04/22
New York Stock Exchange
1.700% Senior Notes due 2024
DHR 1.7 03/30/24
New York Stock Exchange
2.500% Senior Notes due 2025
DHR 2.5 07/08/25
New York Stock Exchange
0.200% Senior Notes due 2026
DHR 0.2 03/18/26
New York Stock Exchange
2.100% Senior Notes due 2026
DHR 2.1 09/30/26
New York Stock Exchange
1.200% Senior Notes due 2027
DHR 1.2 06/30/27
New York Stock Exchange
0.450% Senior Notes due 2028
DHR 0.45 03/18/28
New York Stock Exchange
2.500% Senior Notes due 2030
DHR 2.5 03/30/30
New York Stock Exchange
0.750% Senior Notes due 2031
DHR 0.75 09/18/31
New York Stock Exchange
1.350% Senior Notes due 2039
DHR 1.35 09/18/39
New York Stock Exchange
1.800% Senior Notes due 2049
DHR 1.8 09/18/49
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
 
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 







ITEM 2.02
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 23, 2020, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended July 3, 2020. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
 
 
 
(c)

Exhibits:
 
 
 
Exhibit No.
  
Description
 
 
99.1

  
 
 
 
104

 
The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
DANAHER CORPORATION
 
 
 
 
Date:
July 23, 2020
By:
/s/ Matthew R. McGrew
 
 
 
Matthew R. McGrew
 
 
 
Executive Vice President and Chief Financial Officer



 EX-99.1 2 dhr-2020723xex991.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1
dhrlogofor8ksa62.jpg
DANAHER REPORTS SECOND QUARTER 2020 RESULTS
WASHINGTON, D.C., July 23, 2020 -- Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended July 3, 2020. All results in this release reflect only continuing operations unless otherwise noted.
For the second quarter 2020, net earnings were $927.3 million, or $1.24 per diluted common share which represents a 38.0% year-over-year increase from the comparable 2019 period.
Non-GAAP adjusted diluted net earnings per common share were $1.44 which represents a 32.0% increase over the comparable 2019 period. Revenues increased 19.0% year-over-year to $5.3 billion, with 3.5% non-GAAP core revenue growth including Cytiva.
Operating cash flow for the second quarter 2020 was $1.4 billion, representing a 37.0% increase year-over-year, and non-GAAP free cash flow was $1.3 billion, representing a 41.0% increase year-over-year.
For the third quarter 2020 the Company anticipates that non-GAAP core revenue growth including Cytiva will be in the mid- to high-single digit range.
Thomas P. Joyce, Jr., President and Chief Executive Officer, stated, “We are very pleased with our second quarter results—especially in such a challenging environment. Our solid revenue growth, strong cash flow generation and more than 30% adjusted EPS growth are a testament to our team’s commitment to the Danaher Business System and the outstanding portfolio of businesses that comprise Danaher today.”
Joyce continued, “We are tackling the challenges presented by the COVID-19 pandemic head-on, providing critical diagnostic testing capabilities and accelerating our customers’ pursuit of new vaccines and treatments. We’re fortunate to navigate through this environment from a position of strength and believe that the combination of our team’s DBS-driven execution, resilient portfolio and strong balance sheet uniquely position Danaher in 2020 and beyond.”
Danaher will discuss its results during its quarterly investor conference call on July 23, 2020 starting at 8:00 a.m. ET. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s website, www.danaher.com, under the subheading “Events & Presentations.” A replay of the webcast will be available in the same section of Danaher’s website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.
The conference call can be accessed by dialing 866-503-8675 within the U.S. or by dialing +1 786-815-8792 outside the U.S. a few minutes before the 8:00 a.m. ET start and telling the operator that you are dialing in for Danaher’s earnings conference call (access code 5251859). A replay of the conference call will be available shortly after the conclusion of the call and until August 6, 2020. You can access the replay dial-in information on the “Investors” section of Danaher’s website under the subheading “Events & Presentations.” In addition, presentation materials relating to Danaher’s results have been posted to the “Investors” section of Danaher’s website under the subheading “Quarterly Earnings.”
ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher’s globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life’s Potential. For more information, please visit www.danaher.com.
NON-GAAP MEASURES
In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings release also contains non-GAAP financial measures. Calculations of these measures, the reasons why we believe these measures provide useful information to investors, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these non-GAAP measures are included in the supplemental reconciliation schedule attached.

1

FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical, including statements regarding the Company's anticipated third quarter financial performance, the Company’s contributions to the response to the COVID-19 pandemic, the positioning of the Company’s portfolio, the Company’s differentiation and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, the highly uncertain and unpredictable severity, magnitude and duration of the COVID-19 pandemic (and the related governmental, business and community responses thereto) on our business, results of operations and financial condition, Danaher's ability to successfully integrate the operations and employees of the Biopharma business Danaher acquired from General Electric Company (now known as Cytiva) with Danaher's existing business, the ability to realize anticipated financial, tax and operational synergies and benefits from such acquisition, Cytiva's performance and maintenance of important business relationships, the impact of our debt obligations (including the debt incurred to finance the acquisition of Cytiva) on our operations and liquidity, deterioration of or instability in the economy, the markets we serve and the financial markets (including as a result of the COVID-19 pandemic), developments and uncertainties in U.S. policy stemming from the U.S. administration, such as changes in U.S. trade and tariff policies and the reaction of other countries thereto, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments and successfully complete divestitures and other dispositions, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of our information technology systems or violations of data privacy laws, the impact of our restructuring activities on our ability to grow, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights of the United States government to use, disclose and license certain intellectual property we license if we fail to commercialize it, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, the impact of deregulation on demand for our products and services, labor matters, international economic, political, legal, compliance and business factors (including the impact of the United Kingdom's separation from the EU and uncertainty relating to the terms of such separation), disruptions relating to man-made and natural disasters (including pandemics such as COVID-19) and pension plan costs. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2019 Annual Report on Form 10-K, our first and second quarter 2020 Quarterly Reports on Form 10-Q and our Prospectus Supplement filed with the SEC on April 6, 2020 pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
CONTACT
Matthew E. Gugino
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860

2

DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS (unaudited)
($ and shares in millions, except per share amounts)
 
Three-Month Period Ended
 
Six-Month Period Ended
 
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
 
Sales
$
5,297.4

 
$
4,444.5

 
$
9,640.5

 
$
8,664.7

 
Cost of sales
(2,444.8
)
 
(1,960.7
)
 
(4,345.1
)
 
(3,826.0
)
 
Gross profit
2,852.6

 
2,483.8

 
5,295.4

 
4,838.7

 
Operating costs:
 
 
 
 
 
 
 
 
Selling, general and administrative expenses
(1,685.4
)
 
(1,390.0
)
 
(3,143.7
)
 
(2,757.7
)
 
Research and development expenses
(322.6
)
 
(282.1
)
 
(609.6
)
 
(549.6
)
 
Operating profit
844.6

 
811.7

 
1,542.1

 
1,531.4

 
Nonoperating income (expense):
 
 
 
 
 
 
 
 
Other (expense) income, net
(0.7
)
 
5.0

 
(2.2
)
 
10.1

 
Gain on sale of product lines
454.6

 
—

 
454.6

 
—

 
Interest expense
(78.6
)
 
(19.7
)
 
(126.0
)
 
(40.2
)
 
Interest income
1.0

 
26.2

 
63.5

 
41.9

 
Earnings from continuing operations before income taxes
1,220.9

 
823.2

 
1,932.0

 
1,543.2

 
Income taxes
(293.6
)
 
(146.8
)
 
(409.6
)
 
(534.5
)
 
Net earnings from continuing operations
927.3

 
676.4

 
1,522.4

 
1,008.7

 
Earnings from discontinued operations, net of income taxes
—

 
54.9

 
—

 
56.4

 
Net earnings
927.3

 
731.3

 
1,522.4

 
1,065.1

 
Mandatory convertible preferred stock dividends
(34.6
)
 
(22.7
)
 
(54.2
)
 
(29.2
)
 
Net earnings attributable to common stockholders
$
892.7

 
$
708.6

 
$
1,468.2

 
$
1,035.9

 
Net earnings per common share from continuing operations:
 
 
 
 
 
 
 
 
Basic
$
1.27

 
$
0.91

 
$
2.09

(b) 
$
1.37

 
Diluted
$
1.24

 
$
0.90

 
$
2.06

(b) 
$
1.36

 
Net earnings per common share from discontinued operations:
 
 
 
 
 
 
 
 
Basic
$
—

 
$
0.08

 
$
—

 
$
0.08

 
Diluted
$
—

 
$
0.08

 
$
—

 
$
0.08

 
Net earnings per common share:
 
 
 
 
 
 
 
 
Basic
$
1.27

 
$
0.99

 
$
2.09

(b) 
$
1.45

 
Diluted
$
1.24

 
$
0.97

(a) 
$
2.06

(b) 
$
1.43

(a) 
Average common stock and common equivalent shares outstanding:
 
 
 
 
 
 
 
 
Basic
705.1

 
717.6

 
701.1

 
712.6

 
Diluted
718.2

 
727.9

 
713.1

 
723.2

 
(a) Net earnings per common share does not add due to rounding.
(b) Net earnings per common share amounts for the relevant three-month periods do not add to the six-month period amounts due to rounding.

This information is presented for reference only. A complete copy of Danaher’s Form 10-Q financial statements is available on the Company’s website (www.danaher.com).


3
DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

Adjusted Diluted Net Earnings Per Common Share from Continuing Operations 1
 
Three-Month Period Ended
 
Six-Month Period Ended
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
Diluted Net Earnings Per Common Share from Continuing Operations (GAAP)
$
1.24

 
$
0.90

 
$
2.06

 
$
1.36

Pretax amortization of acquisition-related intangible assets A
0.43

 
0.21

 
0.65

 
0.43

Pretax acquisition-related fair value adjustments to inventory and deferred revenue, incremental transaction costs deemed significant and integration preparation costs, in each case related to the acquisition of Cytiva B
0.31

 
0.03

 
0.39

 
0.05

Pretax impairment charges related to a facility in the Diagnostics segment and a trade name and other intangible assets in the Environmental & Applied Solutions segment C
—

 
—

 
0.01

 
—

Pretax fair value adjustments and losses on the Company's equity and limited partnership investments D
0.01

 
—

 
0.02

 
—

Gain on the sale of certain product lines in the Life Sciences segment in the second quarter of 2020 E
(0.62
)
 
—

 
(0.62
)
 
—

Tax effect of all adjustments reflected above F
0.05

 
(0.04
)
 
—

 
(0.09
)
Discrete tax adjustments and other tax-related adjustments G
—

 
(0.02
)
 
(0.04
)
 
0.31

Declared dividends on the MCPS assuming “if-converted” method H
0.02

 
0.01

 
0.03

 
0.02

Adjusted Diluted Net Earnings Per Common Share from Continuing Operations (Non-GAAP)
$
1.44

 
$
1.09

 
$
2.50

 
$
2.08

1 
Each of the per share amounts above have been calculated assuming the Mandatory Convertible Preferred Stock (“MCPS”) had been converted into shares of common stock.
Adjusted Diluted Shares Outstanding
 
Three-Month Period Ended
 
Six-Month Period Ended
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
(shares in millions)
 
 
 
 
 
 
 
Average common stock and common equivalent shares outstanding - diluted
718.2

 
727.9

 
713.1

 
723.2

Converted shares 2
16.8

 
11.9

 
14.6

 
8.1

Adjusted average common stock and common equivalent shares outstanding - diluted
735.0

 
739.8

 
727.7

 
731.3

2 
The number of converted shares assumes the conversion of all MCPS and issuance of the underlying shares applying the “if-converted” method of accounting and using an average 20 trading-day trailing volume weighted average price (“VWAP”) of $172.83 and $139.04 as of July 3, 2020 and June 28, 2019, respectively.

See the accompanying Notes to Reconciliation of GAAP to Non-GAAP Financial Measures


4
DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)

Core Sales Growth and Core Sales Growth Including Cytiva
 
% Change Three-Month Period Ended July 3, 2020 vs. Comparable 2019 Period
 
% Change Six-Month Period Ended July 3, 2020 vs. Comparable 2019 Period
Total sales growth (GAAP)
19.0
 %
 
11.5
 %
Impact of:
 
 
 
Acquisitions/divestitures
(21.5
)%
 
(11.0
)%
Currency exchange rates
2.0
 %
 
1.5
 %
Core sales growth (decline) (non-GAAP)
(0.5
)%
 
2.0
 %
Impact of Cytiva sales growth (net of divested product lines)
4.0
 %
 
2.0
 %
Core sales growth including Cytiva (non-GAAP)
3.5
 %
 
4.0
 %
Forecasted Core Sales Growth and Core Sales Growth Including Cytiva
 
% Change Three-Month Period Ending October 2, 2020 vs. Comparable 2019 Period
Core sales growth (non-GAAP)
+Low- to mid-single digit
Impact of Cytiva sales growth (net of divested product lines)
~300-400 bps
Core sales growth including Cytiva (non-GAAP)
+Mid- to high-single digit

See the accompanying Notes to Reconciliation of GAAP to Non-GAAP Financial Measures

5
DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)

Reconciliation of Operating Cash Flows from Continuing Operations (GAAP) to Free Cash Flow from Continuing Operations (Non-GAAP)
 
Three-Month Period Ended
 
Year-over-Year Change
 
July 3, 2020
 
June 28, 2019
 
Cash Flows from (used in) Continuing Operations ($ in millions):
 
 
 
 
 
Operating Cash Flows from Continuing Operations (GAAP)
$
1,445.0

 
$
1,056.4

 
 
Investing Cash Flows from (used in) Continuing Operations (GAAP)
$
539.3

 
$
(202.3
)
 
 
Financing Cash Flows (used in) from Continuing Operations (GAAP)
$
(888.0
)
 
$
605.0

 
 
 
 
 
 
 
 
Free Cash Flow from Continuing Operations ($ in millions):
 
 
 
 
 
Operating Cash Flows from Continuing Operations (GAAP)
$
1,445.0

 
$
1,056.4

 
≈ 37.0%
Less: payments for additions to property, plant and equipment (capital expenditures) from continuing operations (GAAP)
(155.4
)
 
(154.3
)
 
 
Plus: proceeds from sales of property, plant and equipment (capital disposals) from continuing operations (GAAP)
0.3

 
11.2

 
 
Free Cash Flow from Continuing Operations (Non-GAAP)
$
1,289.9

 
$
913.3

 
≈ 41.0%
 
 
 
 
 
 
Ratio of Free Cash Flow from Continuing Operations to Net Earnings from Continuing Operations ($ in millions):
 
 
 
 
 
Free Cash Flows from Continuing Operations from Above (GAAP)
$
1,289.9

 
$
913.3

 
 
Net Earnings from Continuing Operations (GAAP)
927.3

 
676.4

 
 
Free Cash Flow from Continuing Operations to Net Earnings from Continuing Operations Conversion Ratio (Non-GAAP)
1.39

 
1.35

 

We define free cash flow as operating cash flows from continuing operations, less payments for additions to property, plant and equipment from continuing operations (“capital expenditures”) plus the proceeds from sales of plant, property and equipment from continuing operations (“capital disposals”).

See the accompanying Notes to Reconciliation of GAAP to Non-GAAP Financial Measures


6
DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)

Notes to Reconciliation of GAAP to Non-GAAP Financial Measures
A 
Amortization of acquisition-related intangible assets in the following historical periods ($ in millions) (only the pretax amounts set forth below are reflected in the amortization line item above):
 
Three-Month Period Ended
 
Six-Month Period Ended
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
Pretax
$
314.1

 
$
156.3

 
$
470.5

 
$
313.7

After-tax
252.9

 
126.1

 
378.8

 
252.9

B 
Pretax costs incurred for fair value adjustments to inventory and deferred revenue related to the Cytiva Acquisition in the three-month period ended July 3, 2020 ($228 million pretax as reported in this line item, $178 million after-tax) and fair value adjustments to inventory and deferred revenue, transaction costs deemed significant and integration preparation costs related to the Cytiva Acquisition for the six-month period ended July 3, 2020 ($288 million pretax as reported in this line item, $231 million after-tax). Pretax costs incurred for transaction costs deemed significant and integration preparation costs related to the Cytiva Acquisition for the three-month period ended June 28, 2019 ($18 million pretax as reported in this line item, $16 million after-tax) and the six-month period ended June 28, 2019 ($33 million pretax as reported in this line item, $29 million after-tax). The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company’s larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.
C 
Pretax impairment charges related to a facility in the Diagnostics segment and a trade name and other intangible assets in the Environmental & Applied Solutions segment recorded in the six-month period ended July 3, 2020 ($8 million pretax as reported in this line item, $6 million after-tax).
D 
Pretax fair value adjustments and losses on the Company's equity and limited partnership investments recorded in the three and six-month periods ended July 3, 2020 ($6 million pretax as reported in this line item, $4 million after-tax and $13 million pretax as reported in this line item, $10 million after-tax, respectively).
E 
Pretax gain on the sale of certain product lines in the Life Sciences segment in the three and six-month periods ended July 3, 2020 ($455 million pretax as reported in this line item, $305 million after-tax).
F 
This line item reflects the aggregate tax effect of all nontax adjustments reflected in the preceding line items of the table. In addition, the footnotes above indicate the after-tax amount of each individual adjustment item. Danaher estimates the tax effect of each adjustment item by applying Danaher’s overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment. The MCPS dividends are not tax deductible and therefore the tax effect of the adjustments does not include any tax impact of the MCPS dividends.
G 
Discrete tax adjustments and other tax-related adjustments for the six-month period ended July 3, 2020, include the impact of net discrete tax gains of $27 million (or $0.04 per diluted common share) related primarily to excess tax benefits from stock-based compensation and the release of reserves for uncertain tax positions due to the expiration of statutes of limitation. Discrete tax adjustments and other tax-related adjustments for the three-month period ended June 28, 2019 includes the impact of net discrete tax gains of $18 million or $0.02 per diluted common share. Discrete tax adjustments and other tax-related adjustments for the six-month period ended June 28, 2019 includes the impact of net discrete tax charges of $227 million or $0.31 per diluted common share. The discrete tax matters for the six-month period ended June 28, 2019 relate primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of valuation allowances associated with certain foreign tax credits and tax benefits resulting from a change in law and excess tax benefits from stock-based compensation realized in the three and six-month periods ended June 28, 2019 in excess of anticipated levels. The Company anticipates excess tax benefits from stock compensation of approximately $7 million per quarter and therefore excludes benefits in excess of this amount in the calculation of Adjusted Diluted Net Earnings Per Common Share from Continuing Operations.
H 
In March 2019, the Company issued $1.65 billion in aggregate liquidation preference of 4.75% MCPS. In May 2020. the Company issued $1.72 billion in aggregate liquidation preference of 5.0% MCPS. Dividends on the 4.75% and 5.0% MCPS are payable on a cumulative basis at an annual rate of 4.75% and 5.0%, respectively, on the liquidation preference of $1,000 per share. Unless earlier converted, each share of 4.75% MCPS will automatically convert on April 15, 2022 into between 6.6549 and 8.1522 shares of Danaher’s common stock, subject to further anti-dilution adjustments. Unless earlier converted, each share of 5.0% MCPS will automatically convert on April 15, 2023 into between 5.0081 and 6.1349 shares of Danaher’s common stock, subject to further anti-dilution adjustments. The number of shares of Danaher’s common stock issuable on conversion of the MCPS will be determined based on the VWAP per share of the Company’s common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2022 and April 15, 2023 for the 4.75% and 5.0% MCPS, respectively. For the purposes of calculating adjusted earnings per share, the Company has excluded the paid and anticipated MCPS cash dividends and assumed the “if-converted” method of share dilution (the incremental shares of common stock deemed outstanding applying the “if-converted” method of calculating share dilution are referred to as the “Converted Shares”.)

7

Statement Regarding Non-GAAP Measures
Each of the non-GAAP measures set forth above should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.  Management believes that these measures provide useful information to investors by offering additional ways of viewing Danaher Corporation’s (“Danaher” or the “Company”) results that, when reconciled to the corresponding GAAP measure, help our investors to:
•
with respect to Adjusted Diluted Net Earnings Per Common Share from Continuing Operations, understand the long-term profitability trends of our business and compare our profitability to prior and future periods and to our peers;
•
with respect to core sales from continuing operations, identify underlying growth trends in our business and compare our sales performance with prior and future periods and to our peers; and
•
with respect to free cash flow (the “FCF Measure”), understand Danaher’s ability to generate cash without external financings, strengthen its balance sheet, invest in its business and grow its business through acquisitions and other strategic opportunities (although a limitation of free cash flow is that it does not take into account the Company’s debt service requirements and other non-discretionary expenditures, and as a result the entire free cash flow amount is not necessarily available for discretionary expenditures).
We also present core sales from continuing operations on a basis that includes sales attributable to Cytiva (formerly the Biopharma Business of General Electric Company’s (“GE”) Life Sciences business), which Danaher acquired from GE on March 31, 2020. Historically Danaher has calculated core sales solely on a basis that excludes sales from acquired businesses recorded prior to the first anniversary of the acquisition. However, given Cytiva’s significant size and historical core sales growth rate, in each case compared to Danaher’s existing businesses, management believes it is appropriate to also present core sales on a basis that includes Cytiva sales. Management believes this presentation provides useful information to investors by demonstrating the impact Cytiva has on the Company’s current growth profile, rather than waiting to demonstrate such impact 12 months after the acquisition when Cytiva would normally have been included in Danaher’s core sales calculation. Danaher calculates period-to-period core sales growth including Cytiva by adding to the baseline period sales Cytiva’s historical sales from such period (when it was owned by GE), net of the sales of the divested product lines and also adding the Cytiva sales to the current period.
Management uses these non-GAAP measures to measure the Company’s operating and financial performance, and uses core sales and non-GAAP measures similar to Adjusted Diluted Net Earnings Per Common Share from Continuing Operations and the FCF Measure in the Company’s executive compensation program.
The items excluded from the non-GAAP measures set forth above have been excluded for the following reasons:
•
With respect to Adjusted Diluted Net Earnings Per Common Share from Continuing Operations:
◦
We exclude the amortization of acquisition-related intangible assets because the amount and timing of such charges are significantly impacted by the timing, size, number and nature of the acquisitions we consummate. While we have a history of significant acquisition activity we do not acquire businesses on a predictable cycle, and the amount of an acquisition’s purchase price allocated to intangible assets and related amortization term are unique to each acquisition and can vary significantly from acquisition to acquisition. Exclusion of this amortization expense facilitates more consistent comparisons of operating results over time between our newly acquired and long-held businesses, and with both acquisitive and non-acquisitive peer companies. We believe however that it is important for investors to understand that such intangible assets contribute to sales generation and that intangible asset amortization related to past acquisitions will recur in future periods until such intangible assets have been fully amortized.
◦
We exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different (in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans) from the ongoing productivity improvements that result from application of the Danaher Business System. Because these restructuring plans are incremental to the core activities that arise in the ordinary course of our business and we believe are not indicative of Danaher’s ongoing operating costs in a given period, we exclude these costs to facilitate a more consistent comparison of operating results over time.
◦
With respect to the other items excluded from Adjusted Diluted Net Earnings Per Common Share from Continuing Operations, we exclude these items because they are of a nature and/or size that occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher's commercial performance

8

during the period and/or we believe that such items may obscure underlying business trends and make comparisons of long-term performance difficult.
◦
Danaher’s Mandatory Convertible Preferred Stock (“MCPS”) will mandatorily convert into Danaher common stock on the mandatory conversion date, which is expected to be April 15, 2022 and April 15, 2023 for the 4.75% and 5.0% MCPS, respectively, (unless converted or redeemed earlier in accordance with the terms of the applicable certificate of designations). On the prior pages, we present the earnings per share-related measures on a basis which assumes the MCPS had already been converted as of the beginning of the applicable period (and accordingly also exclude the dividends that were actually paid on the MCPS during such period, since such dividends would no longer be paid once the MCPS convert). We believe this presentation provides useful information to investors by helping them understand what the net impact will be on Danaher’s earnings per share-related measures once the MCPS convert into Danaher common stock.
•
With respect to core sales from continuing operations and core sales from continuing operations including Cytiva, (1) we exclude the impact of currency translation because it is not under management’s control, is subject to volatility and can obscure underlying business trends, and (2) we exclude the effect of acquisitions (other than Cytiva, in the case of core sales from continuing operations including Cytiva) and divested product lines because the timing, size, number and nature of such transactions can vary significantly from period-to-period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.
•
With respect to the FCF Measure, we exclude payments for additions to property, plant and equipment (net of the proceeds from capital disposals) to demonstrate the amount of operating cash flow for the period that remains after accounting for the Company’s capital expenditure requirements.
With respect to forecasted core sales from continuing operations and forecasted core sales from continuing operations including Cytiva, we do not reconcile these measures to the comparable GAAP measure because of the inherent difficulty in predicting and estimating the future impact and timing of currency translation, acquisitions and divested product lines, which would be reflected in any forecasted GAAP revenue.


9
 EX-101.SCH 3 dhr-20200723.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0002000 - Document - Document And Entity Information Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 dhr-20200723_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 dhr-20200723_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 dhr-20200723_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Document type Document Type Document period end date Document Period End Date Entity registrant name Entity Registrant Name Entity incorporation, state Entity Incorporation, State or Country Code Entity file number Entity File Number Entity tax identification number Entity Tax Identification Number Entity address, address line one Entity Address, Address Line One Entity address, address line two Entity Address, Address Line Two Entity address, city Entity Address, City or Town Entity address, state Entity Address, State or Province Entity address, postal zip code Entity Address, Postal Zip Code City area code City Area Code Local phone number Local Phone Number Written communications Written Communications Soliciting material Soliciting Material Pre-commencement tender offer Pre-commencement Tender Offer Pre-commencement issuer tender offer Pre-commencement Issuer Tender Offer Entity emerging growth company Entity Emerging Growth Company Amendment flag Amendment Flag Entity central index key Entity Central Index Key Entity Listings [Table] Entity Listings [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common stock, $0.01 par value Common Stock [Member] 4.75% Mandatory Convertible Preferred Stock, Series A, without par value Series A Preferred Stock [Member] 5.00% Mandatory Convertible Preferred Stock, Series B, without par value Series B Preferred Stock [Member] Floating Rate Senior Notes due 2022 Floating Rate Senior Notes Due 2022 [Member] Floating Rate Senior Notes Due 2022 Member [Member] 1.700% Senior Notes due 2022 1.7% Senior Notes Due 2022 [Member] 1.7% Senior Notes Due 2022 [Member] 1.700% Senior Notes due 2024 1.7% Senior Notes Due 2024 [Member] 1.7% Senior Notes Due 202 [Member] 2.500% Senior Notes due 2025 2.5% Senior Notes Due 2025 [Member] 2.5% Senior Notes Due 2025 [Member] 0.200% Senior Notes due 2026 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] 2.100% Senior Notes due 2026 2.1% Senior Notes Due 2026 [Member] 2.1% Senior Notes Due 2026 [Member] 1.200% Senior Notes due 2027 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] 0.450% Senior Notes due 2028 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] 2.500% Senior Notes due 2030 2.5% Senior Notes Due 2030 [Member] 2.5% Senior Notes Due 2030 [Member] 0.750% Senior Notes due 2031 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] 1.350% Senior Notes due 2039 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] 1.800% Senior Notes due 2049 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] Entity Listings [Line Items] Entity Listings [Line Items] Title of 12(b) security Title of 12(b) Security Trading symbol Trading Symbol Security exchange name Security Exchange Name EX-101.PRE 7 dhr-20200723_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 dhrlogofor8ksa62.jpg begin 644 dhrlogofor8ksa62.jpg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end GRAPHIC 9 dhrlogofor8ksa63.jpg begin 644 dhrlogofor8ksa63.jpg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end XML 10 dhr-2020723x8k_htm.xml IDEA: XBRL DOCUMENT 0000313616 dhr:A2.5SeniorNotesDue2025Member 2020-07-23 2020-07-23 0000313616 dhr:A0.45SeniorNotesDue2028Member 2020-07-23 2020-07-23 0000313616 dhr:A1.7SeniorNotesDue2024Member 2020-07-23 2020-07-23 0000313616 dhr:A1.35SeniorNotesDue2039Member 2020-07-23 2020-07-23 0000313616 us-gaap:SeriesBPreferredStockMember 2020-07-23 2020-07-23 0000313616 dhr:A1.7SeniorNotesDue2022Member 2020-07-23 2020-07-23 0000313616 dhr:A1.8SeniorNotesDue2049Member 2020-07-23 2020-07-23 0000313616 dhr:A0.75SeniorNotesDue2031Member 2020-07-23 2020-07-23 0000313616 us-gaap:SeriesAPreferredStockMember 2020-07-23 2020-07-23 0000313616 us-gaap:CommonStockMember 2020-07-23 2020-07-23 0000313616 dhr:A2.1SeniorNotesDue2026Member 2020-07-23 2020-07-23 0000313616 dhr:A1.2SeniorNotesDue2027Member 2020-07-23 2020-07-23 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2020-07-23 2020-07-23 0000313616 dhr:A2.5SeniorNotesDue2030Member 2020-07-23 2020-07-23 0000313616 dhr:A0.2SeniorNotesDue2026Member 2020-07-23 2020-07-23 0000313616 2020-07-23 2020-07-23 false 0000313616 8-K 2020-07-23 DANAHER CORPORATION DE 001-08089 59-1995548 2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W, Washington, DC 202 828-0850 false false false false Common stock, $0.01 par value DHR NYSE 4.75% Mandatory Convertible Preferred Stock, Series A, without par value DHR.PRA NYSE 5.00% Mandatory Convertible Preferred Stock, Series B, without par value DHR.PRB NYSE Floating Rate Senior Notes due 2022 DHR F 06/30/22 NYSE 1.700% Senior Notes due 2022 DHR 1.7 01/04/22 NYSE 1.700% Senior Notes due 2024 DHR 1.7 03/30/24 NYSE 2.500% Senior Notes due 2025 DHR 2.5 07/08/25 NYSE 0.200% Senior Notes due 2026 DHR 0.2 03/18/26 NYSE 2.100% Senior Notes due 2026 DHR 2.1 09/30/26 NYSE 1.200% Senior Notes due 2027 DHR 1.2 06/30/27 NYSE 0.450% Senior Notes due 2028 DHR 0.45 03/18/28 NYSE 2.500% Senior Notes due 2030 DHR 2.5 03/30/30 NYSE 0.750% Senior Notes due 2031 DHR 0.75 09/18/31 NYSE 1.350% Senior Notes due 2039 DHR 1.35 09/18/39 NYSE 1.800% Senior Notes due 2049 DHR 1.8 09/18/49 NYSE false XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document And Entity Information Document And Entity Information
Jul. 23, 2020
Cover [Abstract]  
Document type 8-K
Document period end date Jul. 23, 2020
Entity registrant name DANAHER CORPORATION
Entity incorporation, state DE
Entity file number 001-08089
Entity tax identification number 59-1995548
Entity address, address line one 2200 Pennsylvania Avenue, N.W.,
Entity address, address line two Suite 800W,
Entity address, city Washington,
Entity address, state DC
Entity address, postal zip code 20037-1701
City area code 202
Local phone number 828-0850
Written communications false
Soliciting material false
Pre-commencement tender offer false
Pre-commencement issuer tender offer false
Entity emerging growth company false
Amendment flag false
Entity central index key 0000313616
Common stock, $0.01 par value  
Entity Listings [Line Items]  
Title of 12(b) security Common stock, $0.01 par value
Trading symbol DHR
Security exchange name NYSE
4.75% Mandatory Convertible Preferred Stock, Series A, without par value  
Entity Listings [Line Items]  
Title of 12(b) security 4.75% Mandatory Convertible Preferred Stock, Series A, without par value
Trading symbol DHR.PRA
Security exchange name NYSE
5.00% Mandatory Convertible Preferred Stock, Series B, without par value  
Entity Listings [Line Items]  
Title of 12(b) security 5.00% Mandatory Convertible Preferred Stock, Series B, without par value
Trading symbol DHR.PRB
Security exchange name NYSE
Floating Rate Senior Notes due 2022  
Entity Listings [Line Items]  
Title of 12(b) security Floating Rate Senior Notes due 2022
Trading symbol DHR F 06/30/22
Security exchange name NYSE
1.700% Senior Notes due 2022  
Entity Listings [Line Items]  
Title of 12(b) security 1.700% Senior Notes due 2022
Trading symbol DHR 1.7 01/04/22
Security exchange name NYSE
1.700% Senior Notes due 2024  
Entity Listings [Line Items]  
Title of 12(b) security 1.700% Senior Notes due 2024
Trading symbol DHR 1.7 03/30/24
Security exchange name NYSE
2.500% Senior Notes due 2025  
Entity Listings [Line Items]  
Title of 12(b) security 2.500% Senior Notes due 2025
Trading symbol DHR 2.5 07/08/25
Security exchange name NYSE
0.200% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) security 0.200% Senior Notes due 2026
Trading symbol DHR 0.2 03/18/26
Security exchange name NYSE
2.100% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) security 2.100% Senior Notes due 2026
Trading symbol DHR 2.1 09/30/26
Security exchange name NYSE
1.200% Senior Notes due 2027  
Entity Listings [Line Items]  
Title of 12(b) security 1.200% Senior Notes due 2027
Trading symbol DHR 1.2 06/30/27
Security exchange name NYSE
0.450% Senior Notes due 2028  
Entity Listings [Line Items]  
Title of 12(b) security 0.450% Senior Notes due 2028
Trading symbol DHR 0.45 03/18/28
Security exchange name NYSE
2.500% Senior Notes due 2030  
Entity Listings [Line Items]  
Title of 12(b) security 2.500% Senior Notes due 2030
Trading symbol DHR 2.5 03/30/30
Security exchange name NYSE
0.750% Senior Notes due 2031  
Entity Listings [Line Items]  
Title of 12(b) security 0.750% Senior Notes due 2031
Trading symbol DHR 0.75 09/18/31
Security exchange name NYSE
1.350% Senior Notes due 2039  
Entity Listings [Line Items]  
Title of 12(b) security 1.350% Senior Notes due 2039
Trading symbol DHR 1.35 09/18/39
Security exchange name NYSE
1.800% Senior Notes due 2049  
Entity Listings [Line Items]  
Title of 12(b) security 1.800% Senior Notes due 2049
Trading symbol DHR 1.8 09/18/49
Security exchange name NYSE
EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( TS]U '04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " -,_=0%B0@^N\ K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$E&!R;-I:.G#@8K;.QF;+4UBQUC:R1]^SE>FS*V!QCX8NGW MIT_@5GFAAH#/8? 8R&"\FVSOHE!^S4Y$7@!$=4(K8YD2+C4/0["2TC4-^R[J:U[S@#T7=[/E*U/?IO,^N/_QNPG;0YF#^ ML?%5L&OAU[_HO@!02P,$% @ #3/W4)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" -,_=0>^(C9,8' "8-@ & 'AL+W=O?HJ%-@@2P)9X/&]N ;,]@)IGU&/9LC&"1"UIL2<20;(5L M^9"G3S4IJY2L6"5+E"]L4F+__+NJ^'4W39X]J^I[/9=2BY;VF_K'IO/0F<>DEEOXD5QWRC=Y$Y77S6SRWQX;N0$R6M5;%JC$X*+*R_9N\K *Q2P-GU)SJY.*O4LZC,T:!F-IJN-JW!7%::K-SK"K[-H)V^N%:3)019BW&9 MB@^ESO2K^%RVV3918[X_&VDP8:1&D]4)+]L3.ATG_-LR'PK'/1&.Y5C_VWP$ MWM<=<-8=G? M"1/>VH2WFXF%K#*5"@GQ3Q.]U0^M]!;Q'W_X@8FYO_;FDXJK.JCD+#-1!Y-E M4FQU1NMX( M'BUV_8%P%*X=A;LXFF:Y%.6R>)35-B.TAF79IU9D13'A)UK[B7;QHY,7D:50 M8]DTF[27>[<[6M&/3^TX]GTO(NS%:WOQ+O:2-*UD79^\;0ASG%#EUBS2B@X, M4N)6EF7]FC\E99:(\9,LE_)$W P?AB>$9]M"D%K[N];/:BLJ:AP% N_I,MQ$2EVXW1BE!];GAJAY9-&<21P::!?M78@SE8MQ]: (8!R@@. M S;-[R]J H%9S.&:),C!B$1.!&#SJ7')1O3;-*X?JDQK64)@BF)9KJA6;W5% M"TV3O):4)62_38/[7N497&APP<"\3<-@GN1;_= JK!]DOTVC^K:2IR8\LIS( M=I8#4PN80JGIM"-_M![K#+%OTY3^G;.LKI?@C#5(RW(&'42\LQ/BP5PU,_F< M@8*>FV);).56DC*"K#5$NT,S>0P!2YN@3?-DMM4*+QXY&IDU?A:?DMTS")5%-A.W]^ M_(NHY619=8SBC-+>P4 8.S1#OU5):BZ3^K5X5%NAQPAS0T/2&H?]'\4M2PI).5:_B2I6PC-79(R07 M, B@JV0J[MOV+[8P05^W(=I=F^\=<)Q1L M>XAMKS=L,TJ'A<1##GN'61Y3E$A-KR]J M,D)<42(U/9J:1"(\Z@2(2^\HN/01EWYON&24]HR%CYST#^4D([ N2KD* M2>GW14I&B"E*'TGI,S=NAWY7(GSJ!$A*_RBD]#?^4]<;*1FE?6.!I/0/)24C M8(H27 HK'%G1B':%I/3[(B4CQ!4EDM*G26D-G:Y$4+?)?"2E?Q12!DC*H#=2 M,DI[QB) 4@:'DI(1,$4)+@TI;2A*TA62,NB+E(P04Y0!DC+@2&GOE0@D97 4 M4@9(RJ W4C)*^\9BXP&'0TG)"+2DM(45-\,WZ0I)&?1%2D:(*THD9<#-*3OI M$%(G0%(&1R%EB*0,>R,EH[1G+$(D97@H*1F!=D[IO*V^25=(RK O4C)"3%&& M2,J0)J4U]/R.1% /SX1(RO HI R1E&%OI&24]HT%DC(\E)2,0#M\>_[;^$W: MVG@>K"]4,D)<52(J0QJ5W;-[EWHR(T14AD=!982HC'I#):.T9RPB1&5T*"H9 M@?5*IUE^TZX0E5%?J&2$F**,$)41A\JP P\N]215A*B,CH+*"%$9]89*1FG? M6" JHT-1R0BTJ Q],ZL$5-*V$)517ZADA+BJW'AXEIM5NEV9(!_.151&1T%E MC*B,>T,EH[1G+&)$97PH*AF!=E;IKJN2M(6LC/MB)2/$5&6,K(RY?^I$'8.6 M1W8961D?A94QLC+NC96,TKZQ0%;&A[*2$6BK,EH5)>T*41GWA4I&J*LH1QOO M&9EWMGY)S'.0MB:E^#:G>T6C2O'CTJK571;,YEDLK*' #?3Q7D M9K5CWF9:OXQV\5]02P,$% @ #3/W4(.II0/4 0 ,@8 T !X;"]S M='EL97,N>&ULU57;BM1 $/V5IC_ GD1V04D"*BP(*@L[#[YVDDK2T#<[E3'9 MK[<[G=NX#*@/HB^3.J>J3YV^3M;C).&I T R*JG[G':(]BUC?=6!XOTK8T'[ M3&.5&;0F-,39476&+TSKVDD M?"E70"Y.;E,;5X+8V"5VI(I/0!#M.M%WXHK$L)!&-\D$M><GSVL(Y; RU8@Y5/8 MPJ_-E?;8D+@7'^NP#21,=0V]H26,,A$$_:-:U#[(WOV1++'B8O#]X&>C9_QM M, B/#AHQSGALMOZWU)/;ZMQ:.;V3HM4*XMQ_N6&1\74PQ6] MNJ ;2\)#F-,OX7V5NP=2#D*BT OJ1%V#?G%/O3SRTC_@5_J^OH:&#Q+/6S*G M>_P9:C&H-UO58UB7I6J//X7W*+F?&^[_$L4/4$L#!!0 ( TS]U"7BKL< MP !," + 7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$ M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G7&BN"^) M]NK+NY *W3"W\RQ+50/>I"MJ(-.)_#1EZA$VY8<1(86>Y4)88TS<;_3\1C0> M09:'[L#TA(XA+@W#"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P M4:V%&@/8-SF0!)?DJG547>EYIM[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;! M4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%0 M2P,$% @ #3/W4&60>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6% M3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#W MR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L? ME.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH9 M0]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTC MR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_ M/[&\UDX:?^:+X3]>?P%02P$"% ,4 " -,_=0!T%-8H$ "Q $ M @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( TS M]U 6)"#Z[P "L" 1 " :\ !D;V-0&UL4$L! A0#% @ #3/W4'OB(V3& M!P F#8 !@ ("!#@@ 'AL+W=O7!E&UL4$L%!@ ) D /@( (X6 $! end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 16 95 1 false 15 0 false 0 false false R1.htm 0002000 - Document - Document And Entity Information Document And Entity Information Sheet http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation Document And Entity Information Document And Entity Information Cover 1 false false All Reports Book All Reports dhr-2020723x8k.htm dhr-20200723.xsd dhr-20200723_cal.xml dhr-20200723_def.xml dhr-20200723_lab.xml dhr-20200723_pre.xml dhr-2020723xex991.htm dhrlogofor8ksa63.jpg http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dhr-2020723x8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 16, "dts": { "calculationLink": { "local": [ "dhr-20200723_cal.xml" ] }, "definitionLink": { "local": [ "dhr-20200723_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "dhr-2020723x8k.htm" ] }, "labelLink": { "local": [ "dhr-20200723_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "dhr-20200723_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "dhr-20200723.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 43, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 12, "memberStandard": 3, "nsprefix": "dhr", "nsuri": "http://www.danaher.com/20200723", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "dhr-2020723x8k.htm", "contextRef": "D2020Q2FileDateQ2", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0002000 - Document - Document And Entity Information Document And Entity Information", "role": "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation", "shortName": "Document And Entity Information Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "dhr-2020723x8k.htm", "contextRef": "D2020Q2FileDateQ2", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 15, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City area code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity address, address line one" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity address, address line two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity address, city" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity address, postal zip code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity address, state" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity emerging growth company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity file number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity incorporation, state" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]", "terseLabel": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]", "terseLabel": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity tax identification number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local phone number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement issuer tender offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement tender offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security exchange name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dhr_A0.2SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.2% Senior Notes Due 2026 [Member]", "label": "0.2% Senior Notes Due 2026 [Member]", "terseLabel": "0.200% Senior Notes due 2026" } } }, "localname": "A0.2SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A0.45SeniorNotesDue2028Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.45% Senior Notes Due 2028 [Member]", "label": "0.45% Senior Notes Due 2028 [Member]", "terseLabel": "0.450% Senior Notes due 2028" } } }, "localname": "A0.45SeniorNotesDue2028Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A0.75SeniorNotesDue2031Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.75% Senior Notes Due 2031 [Member]", "label": "0.75% Senior Notes Due 2031 [Member]", "terseLabel": "0.750% Senior Notes due 2031" } } }, "localname": "A0.75SeniorNotesDue2031Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.2SeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.2% Senior Notes Due 2027 [Member]", "label": "1.2% Senior Notes Due 2027 [Member]", "terseLabel": "1.200% Senior Notes due 2027" } } }, "localname": "A1.2SeniorNotesDue2027Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.35SeniorNotesDue2039Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.35% Senior Notes Due 2039 [Member]", "label": "1.35% Senior Notes Due 2039 [Member]", "terseLabel": "1.350% Senior Notes due 2039" } } }, "localname": "A1.35SeniorNotesDue2039Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.7SeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.7% Senior Notes Due 2022 [Member]", "label": "1.7% Senior Notes Due 2022 [Member]", "terseLabel": "1.700% Senior Notes due 2022" } } }, "localname": "A1.7SeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.7SeniorNotesDue2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.7% Senior Notes Due 202 [Member]", "label": "1.7% Senior Notes Due 2024 [Member]", "terseLabel": "1.700% Senior Notes due 2024" } } }, "localname": "A1.7SeniorNotesDue2024Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.8SeniorNotesDue2049Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.8% Senior Notes Due 2049 [Member]", "label": "1.8% Senior Notes Due 2049 [Member]", "terseLabel": "1.800% Senior Notes due 2049" } } }, "localname": "A1.8SeniorNotesDue2049Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A2.1SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2.1% Senior Notes Due 2026 [Member]", "label": "2.1% Senior Notes Due 2026 [Member]", "terseLabel": "2.100% Senior Notes due 2026" } } }, "localname": "A2.1SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A2.5SeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2.5% Senior Notes Due 2025 [Member]", "label": "2.5% Senior Notes Due 2025 [Member]", "terseLabel": "2.500% Senior Notes due 2025" } } }, "localname": "A2.5SeniorNotesDue2025Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A2.5SeniorNotesDue2030Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2.5% Senior Notes Due 2030 [Member]", "label": "2.5% Senior Notes Due 2030 [Member]", "terseLabel": "2.500% Senior Notes due 2030" } } }, "localname": "A2.5SeniorNotesDue2030Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_FloatingRateSeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Floating Rate Senior Notes Due 2022 Member [Member]", "label": "Floating Rate Senior Notes Due 2022 [Member]", "terseLabel": "Floating Rate Senior Notes due 2022" } } }, "localname": "FloatingRateSeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20200723", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common stock, $0.01 par value" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Series A Preferred Stock [Member]", "terseLabel": "4.75% Mandatory Convertible Preferred Stock, Series A, without par value" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Series B Preferred Stock [Member]", "terseLabel": "5.00% Mandatory Convertible Preferred Stock, Series B, without par value" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0000313616-20-000123-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313616-20-000123-xbrl.zip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